LY-294,002 hydrochloride,
934389-88-5,
LY 294002 HYDROCHLORIDE,
LY-294002 hydrochloride,
2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one hydrochloride,
SR-01000076245,
2-Morpholin-4-yl-8-phenyl-chromen-4-one,
4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl,
EU-0100710,
BIFK0049,
Ly 294002 HCl,
SCHEMBL5078472,
CHEMBL1398499,
CTK8F0293,
AOB4477,
DTXSID50474691,
LY 294002, Hydrochloride Salt,
BCP17476,
EX-A1710,
Tox21_500710,
ABP000083,
MFCD00270881,
AKOS024456404,
CCG-222014,
LP00710,
NCGC00094060-01,
NCGC00094060-02,
NCGC00261395-01,
RT-013621,
KS-00001829,
L 9908,
389L885,
CU-00000000012-1,
SR-01000076245-1,
SR-01000076245-3,
2-morpholin-4-yl-8-phenylchromen-4-one,hydrochloride,
2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride,
LY294002 Hydrochloride,
LY294002,
CID11957589,
2-morpholino-8-phenyl-4H-chromen-4-one,
LY 294002,
154447-36-6,
LY-294,002 hydrochloride, 98%, selective inhibitor of PI 3-kinase - 10MG 10mg,